About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Tennessee | 983 Studies

Clinical Trials Breast CancerTennessee

Breast Cancer Clinical Trials in Tennessee

Find 983 clinical trials for breast cancer near Tennessee. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Tennessee

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 961-980 of 983 trials

CompletedTrial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing CancersThis is a first-in-human, 3-part study to investigate the safety, tolerability, and effectiveness of ZW25 (zanidatamab) by itself and combined with selected chemotherapy agents in…NCT02892123·Birmingham, Alabama and 16 others CompletedA Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic TumorsThis is a Phase 1a/1b, open-label, multicenter, global, dose-escalation study designed to evaluate the safety, tolerability, immune response, and pharmacokinetics of autogene…NCT03289962·Scottsdale, Arizona and 32 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingPost-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)The FDA has granted marketing authorization for the ProSense® Cryoablation System for the local treatment of patients aged 70 years or older with low-risk early-stage breast…NCT07629206·Glendale, California and 1 other

TerminatedGW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast CancerThis study was designed to be two-part study (Phase I/Phase II). Part I was designed to find the optimal (best) doses of GW572016, docetaxel, and trastuzumab when given together.NCT00251433·Nashville, Tennessee and 4 others

TerminatedA Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast CancerThis study will evaluate the efficacy, safety, and pharmacokinetics of adjuvant atezolizumab in combination with paclitaxel, followed by atezolizumab, dose-dense doxorubicin or…NCT03498716·Concord, California and 363 others

Active not recruitingA Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced DiseaseThe study is intended to show superiority of AZD9833 in combination with palbociclib (a CDK4/6 inhibitor) versus anastrozole (an aromatase inhibitor) and palbociclib as the…NCT04711252·Mobile, Alabama and 262 others

CompletedA Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast CancerThis study is looking at whether Metformin, an agent that is commonly used to treat diabetes, can decrease or affect the ability of breast cancer cells to grow and whether…NCT01101438·Anchorage, Alaska and 343 others

CompletedVitamin D and Breast Cancer Biomarkers in Female PatientsRATIONALE: Vitamin D may help prevent breast cancer. PURPOSE: This randomized clinical trial is studying vitamin D and breast cancer biomarkers in female patients.NCT01224678·Anniston, Alabama and 102 others

CompletedDS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]This study will compare DS 8201a to standard treatment. Participants must have HER2 breast cancer that has been treated before.NCT03523585·Chandler, Arizona and 226 others

CompletedAn Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)This multi-center, prospective observational study will evaluate the treatment patterns, and the safety in patients with HER2-positive (HER2+) metastatic breast cancer (MBC).NCT01615068·Birmingham, Alabama and 141 others

CompletedStudy of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast CancerThe purpose of this trial is to explore the clinical utility of the three investigational agents in HR+, HER2- breast cancer.NCT02088684·Birmingham, Alabama and 10 others

CompletedSafety, Pharmacokinetics (PK) of AKT and MEK CombinationThis study is a Phase 1 dose-escalation open-label study to determine the recommended Phase II dose (RP2D) and regimen for the combination of the orally administered MEK inhibitor…NCT01138085·Aurora, Colorado and 9 others

CompletedCisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain MetastasesThis randomized phase II trial studies how well cisplatin works with or without veliparib in treating patients with triple-negative breast cancer and/or BRCA mutation-associated…NCT02595905·Anchorage, Alaska and 809 others

SuspendedCANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2The purpose of this study is to test the CANscript™ sensitivity assay, which is a new and different assay developed to test the sensitivity of different cancer types to physician…NCT03253575·Gilbert, Arizona and 29 others

CompletedLapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast CancerIn this research study we are studying the effects of the combination of lapatinib plus Herceptin in subjects with breast cancer that has spread outside of the breast.NCT00470704·Birmingham, Alabama and 8 others

CompletedEffect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and PegfilgrastimThe purpose of this study is to determine if patient education can affect patient reported bone pain in breast cancer patients receiving chemotherapy and pegfilgrastim.NCT01752907·Fountain Valley, California and 50 others

TerminatedSafety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast CancerThis Phase I/II study is designed to assess the safety and therapeutic effect of INCB007839 in combination with trastuzumab and vinorelbine in patients with metastatic HER2+…NCT01254136·Fayetteville, Arkansas and 13 others

CompletedA Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast CancerThe combination of docetaxel and gemcitabine has shown significant activity in patients with metastatic breast cancer.NCT00191672·Nashville, Tennessee and 1 other

TerminatedDocetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast CancerRATIONALE: Dose-dense scheduling with (peg)filgrastim support may improve the clinical and pathologic complete response rate (pCR) and safety profile of single agent neoadjuvant…NCT00343512·Nashville, Tennessee and 1 other

CompletedNeoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast CancerThis trial will examine the combination of sunitinib plus paclitaxel and carboplatin as neoadjuvant treatment for locally advanced breast cancer.NCT00887575·Fort Lauderdale, Florida and 13 others

PreviousPage 49 of 50Next

Other Conditions in Tennessee

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma